Stock PTEC PRINCIPAL TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Principal Technologies Inc.

Equities

PTEC

CA74260Q1028

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 16:00:00 16/04/2024 BST 		5-day change 1st Jan Change
0.15 CAD -.--% Intraday chart for Principal Technologies Inc. -.--% +11.11%
06-07 Principal Technologies Doubles Private Placement of Share Units to Raise $2 Million MT
04-03 Principal Technologies Announced Loan Financing and Private Placement and Updated On Vivostat A/S Acquisition MT

Business Summary

Principal Technologies Inc. is a Canada-based company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. It operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The Company's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Health-care Technology
100.0 %
0 100.0 % 0 100.0 % +25.43%

Sales per region

CAD in Million2022Weight2023Weight Delta
Austria
100.0 %
0 100.0 % 0 100.0 % +25.43%

Managers

Managers TitleAgeSince
Gerald Trent CEO
 Chief Executive Officer 45 -
Peter L. McKeown DFI
 Director of Finance/CFO 68 05/03/23

Members of the board

Members of the board TitleAgeSince
Alfred von Liechtenstein BRD
 Director/Board Member 53 03/08/21
Leopold Specht BRD
 Director/Board Member 68 03/08/21
Gerald Trent CEO
 Chief Executive Officer 45 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,868,627 19,638,627 ( 59.75 %) 0 59.75 %

Shareholders

NameEquities%Valuation
Simplon Asset Management Ltd.
38.50 %
12,500,000 38.50 % 1 M $
Ilse Christa Eder
3.757 %
1,220,000 3.757 % 134 200 $
Alfred von Liechtenstein
0.8316 %
270,000 0.8316 % 29 700 $
Leopold Specht
0.5544 %
180,000 0.5544 % 19 800 $
Gerald Trent
0.5544 %
180,000 0.5544 % 19 800 $
Peter L. McKeown
0.3080 %
100,000 0.3080 % 11 000 $

Company contact information

Principal Technologies, Inc.

700 West Georgia Street Suite 2500

V7Y 1B3, Vancouver

+

http://www.principal-technologies.com
address Principal Technologies Inc.(PTEC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PRINCIPAL TECHNOLOGIES INC. Stock Principal Technologies Inc.
+11.11% 3.59M
MODERNA, INC. Stock Moderna, Inc.
+38.66% 52.85B
LONZA GROUP AG Stock Lonza Group AG
+35.57% 38.24B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-7.81% 38.87B
CELLTRION, INC. Stock Celltrion, Inc.
-10.77% 26.79B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.77% 26.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-17.82% 19.9B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+35.09% 13.18B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-3.05% 11.79B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PTEC Stock
  4. Company Principal Technologies Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW